- $541.80m
- $513.01m
- $4.19m
- 46
- 14
- 53
- 30
Annual cashflow statement for Anterix, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -37.6 | -54.4 | -37.5 | -16.3 | -9.13 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 7.54 | 21.4 | 3.58 | -19.8 | -25.3 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.72 | 19.4 | 49.4 | 6.24 | 74.8 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -27.8 | -9.96 | 17.9 | -27.3 | 42 |
| Capital Expenditures | -7.56 | -14.2 | -27.4 | -27.1 | -17.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | 25.4 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.56 | -14.2 | -27.4 | -27.1 | 8.09 |
| Financing Cash Flow Items | -0.566 | — | -1.46 | -1.56 | -1.24 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 96.1 | 4.22 | -2.42 | -8.06 | -25.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 60.7 | -19.9 | -11.9 | -62.4 | 24.9 |